Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy.
Saved in:
| Title: | Safety and efficacy of epicutaneous immunotherapy with DBV712 (peanut patch) in peanut allergy. |
|---|---|
| Authors: | Dupont C; Pediatric Gastroenterology Department, Marcel Sembat Clinic, Ramsay Group, Boulogne Billancourt, France., Burks AW; Division of Pediatric Allergy and Immunology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Fleischer DM; Children's Hospital Colorado, Section of Allergy and Immunology, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA., Bee KJ; DBV Technologies, Basking Ridge, NJ, United States., Chainani S; DBV Technologies, Basking Ridge, NJ, United States., Sampson HA; DBV Technologies, Basking Ridge, NJ, United States.; Department of Pediatrics, Division of Allergy & Immunology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. |
| Source: | Expert review of clinical immunology [Expert Rev Clin Immunol] 2024 Jun; Vol. 20 (6), pp. 623-633. Date of Electronic Publication: 2024 Feb 14. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 101271248 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8409 (Electronic) Linking ISSN: 1744666X NLM ISO Abbreviation: Expert Rev Clin Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1744-8409 |
|---|---|
| DOI: | 10.1080/1744666X.2024.2315221 |
